Stock Market Today With IBD

Nvidia earnings miss as Dow breaks 200-day MA; Target, Rhythm Pharma, AMG in focus

28 min Listen to the original Episode page
NvidiaMarket IndicesHealthcareFederal ReserveCybersecurityTargetRhythm PharmaAMG

Summary

Speakers note the Nasdaq's modest gain while the Dow broke below its 200-day moving average. Nvidia reported doubled revenue but fell due to SEC scrutiny and leadership uncertainty. Healthcare insurers declined on fraud curtailment news, while Target showed a technical breakout. Rhythm Pharma and AMG were highlighted for institutional interest and buy signals respectively.

Episode sections

  1. 0:09 – 2:06

    Market Overview and Index Performance

    Speakers discuss the NASDAQ's small gain and the Dow's significant decline, noting the Dow breaking below its 200-day moving average. The S&P 500 is described as testing its 200-day line while the Russell 2000 shows modest gains near lows.

  2. 2:06 – 6:04

    NVIDIA Earnings and Market Sentiment

    NVIDIA reported strong earnings with doubled revenue and raised guidance, yet the stock fell nearly 3%. Speakers attribute the drop to an SEC investigation launch and leadership uncertainty, noting the stock failed to lift the broader Nasdaq despite the positive results.

  3. 6:04 – 10:45

    Healthcare Sector Weakness and Fed Policy

    Healthcare stocks, particularly insurers like United Health, declined sharply due to government fraud curtailment efforts. The 10-year Treasury yield fell, and Fed Governor Waller's comments about a potential 50 basis point rate hike in December caused market volatility, though futures suggest a 25 basis point hike is more likely.

  4. 10:45 – 17:36

    Cybersecurity and Consumer Discretionary Strength

    Cybersecurity stocks, including Palo Alto Networks, outperformed the market ahead of earnings. In consumer discretionary, Amazon showed strength near a breakout point, while the upcoming IPO of Anthropic is generating significant interest with rumors of a higher-than-expected price.

  5. 17:36 – 21:14

    Target Earnings and Breakout

    Target reported strong earnings with 49% growth and executed a technical breakout above a cup-with-handle pattern. Despite closing off session highs due to broader market weakness, the stock rose 4% on expanded volume, signaling a positive turnaround under new management.

  6. 21:14 – 28:27

    Rhythm Pharmaceuticals and AMG Analysis

    Rhythm Pharmaceuticals is highlighted for revenue growth from a rare genetic obesity drug and strong institutional sponsorship, despite being unprofitable. AMG is noted for moving back into a buy zone with a high composite rating, driven by its model of owning stakes in investment boutiques.

Assets discussed

AssetKindStanceContext
Nasdaq CompositeindexneutralIt's Alyssa Quorum along with Ken Shreve and the NASDAQ eking out again today.
S&P 500indexneutralYes, yes. We are still looking for day one of a rally attempt for the S P 500.
NVIDIANVDAequityneutraltenths of a percent. And uh we'll see. It it looks like it closed in the middle and maybe even in the top half of its uh of its range today. So uh we will we will take that uh Ali. You can see multiple down days in a row for the for the Nasdaq, and it was a pretty good earnings report for uh NVIDIA.
HUMANA INCHUMequityneutralthat fell that fell sharply uh yesterday. Saw So you know the news yesterday. and this hit names like United Health and CNC Centen and Humana, uh Cigna, all of these, uh, all of these stocks, ticker CI.
Crude oilcommodityneutralenergy prices were down uh sharply uh today, along with that uh 10-year treasury yield. But oil prices at last check, they were down close to four percent today.
AmazonAMZNequitymixedWell this is you know the consumer discretionary some of the top holdings of uh of uh X XLY, uh Amazon obviously a big uh performer today.
AlphabetGOOGLequityneutralAmazon is a big holder or a big uh investor in anthropic along with uh Alphabet.

“Stance” is how the speakers talked about the asset, not a recommendation.

Claims worth verifying

NVIDIA's Q2 fiscal 2027 earnings and revenue doubled year-over-year, and FY2028 revenue guidance was raised to 75% top-line growth versus FactSet's 70% expectation.

Unidentified speaker (speaker_1) ·4:07

How to verify: NVIDIA Q2 FY2027 Earnings Press Release and SEC Filing (8-K) available on NVIDIA Investor Relations or SEC EDGAR. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

The SEC investigation into NVIDIA was launched the day before the earnings report (November 17, 2026).

Unidentified speaker (speaker_1) ·4:46

How to verify: SEC EDGAR filings or news reports from November 17, 2026, regarding the SEC investigation. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

NVIDIA's board intends to hire a new CEO and does not plan to bring Jensen Huang back as CEO.

Unidentified speaker (speaker_1) ·5:06

How to verify: NVIDIA Q2 FY2027 Earnings Conference Call transcript or press release available on NVIDIA Investor Relations. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

United Health (UNH) stock fell 10% on the day following a previous day's decline.

Unidentified speaker (speaker_1) ·6:24

How to verify: United Health (UNH) stock price history and news reports for November 17-18, 2026. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Oil prices dropped below $83 a barrel, down nearly 4% on the day.

Unidentified speaker (speaker_1) ·7:43

How to verify: Bloomberg or Reuters commodity data for WTI or Brent crude oil prices on November 18, 2026. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

The 10-year Treasury yield fell to approximately 5.07%, testing its 50-day moving average.

Unidentified speaker (UNKNOWN) ·8:01

How to verify: U.S. Treasury yield data from the Federal Reserve or financial news providers like Bloomberg for November 18, 2026. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Fed Governor Waller stated on CNBC that a 50 basis point rate hike in December is being considered seriously.

Unidentified speaker (speaker_1) ·8:41

How to verify: CNBC interview transcript or video of Fed Governor Waller with Steve Leisman on November 18, 2026. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Amazon and Alphabet own approximately 30% of Anthropic.

Unidentified speaker (speaker_1) ·13:30

How to verify: Anthropic S-1 filing or press releases detailing investment rounds and ownership stakes. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

Target reported 49% earnings growth and 7% top-line growth, executing a technical breakout above a cup-with-handle pattern.

Unidentified speaker (speaker_0) ·18:16

How to verify: Target Q3 FY2026 Earnings Press Release and SEC Filing (10-K or 8-K) available on Target Investor Relations. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

Rhythm Pharmaceuticals generates revenue from an FDA-approved drug for a rare genetic form of obesity, with MCVRI as the drug name.

Unidentified speaker (speaker_1) ·22:09

How to verify: Rhythm Pharmaceuticals (RYTM) SEC filings (10-K/10-Q) and FDA approval notices for MCVRI (revumenib). For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.

Primary source

Do your own research

  • Verify Nvidia's Q2 FY2027 earnings report and FY2028 guidance against FactSet consensus estimates.
  • Check SEC filings for details on the investigation and board decisions regarding CEO Jensen Huang.
  • Review United Health's recent press releases regarding government fraud curtailment efforts.
  • Monitor CME FedWatch Tool for current probability of a 50bp vs 25bp rate hike.
  • Confirm Anthropic's IPO pricing and Amazon/Alphabet ownership stakes via official SEC filings or reputable financial news.
  • Check Target's technical chart for the cup-with-handle breakout confirmation and volume data.
  • Review Rhythm Pharmaceuticals' revenue growth drivers and institutional ownership filings.
  • Assess AMG's composite rating and investment boutique stake model via recent analyst reports.
Full transcriptexpand
0:09
Unidentified speaker (UNKNOWN): Good
0:10
Unidentified speaker (speaker_0): afternoon, everyone, and welcome to Stock Market today for Wednesday, November 18th. It's Alyssa Quorum along with Ken Shreve and the NASDAQ eking out again today. But where does that leave us with the market direction? We'll get to that soon, as well as a couple of stocks. What's on your radar, Ken?
0:28
Unidentified speaker (speaker_1): Well, uh more good movement underneath the surface uh today, Allie. And we did manage a small gain in the NASDAQ, uh, like you said. So uh let's start by taking a look at uh Target, which had a pretty nice earnings report uh today, sort of battling with uh NVIDIA, which had nice earnings. But um yeah, so Target uh we'll take a look at Target.
0:48
Unidentified speaker (speaker_1): Also a biotech uh rhythm pharma. pharmaceuticals, always looking at that biotech uh sector RYTM as the ticker for rhythm pharmaceuticals, and then uh asset manager AMG, affiliated managers group.
1:05
Unidentified speaker (UNKNOWN): All
1:05
Unidentified speaker (speaker_0): right, we'll check out those stocks, but first a closer look at the major indexes. Here's the NASDAQ composite, finishing up on the day by about four-tenths four tenths of a percent.
1:15
Unidentified speaker (speaker_0): The Russell 2000 was also in positive territory today, but it's hovering near lows as well, up four tenths of a percent. On the downside, the Dow, definitely the hardest hit here today, can down 1.1%, and now solidly below its own 200A 200 day line, joining the Nasdaq.
1:35
Unidentified speaker (speaker_0): The S SP P 500 also finished lower by about a quarter of a percent. It's right around the 200 day. So a test still in progress here.
1:47
Unidentified speaker (speaker_1): Yes, yes. We are still looking for day one of a rally attempt for the S P 500. But uh, you know, we did we did get one, uh we did get uh a first day of a rally attempt for the NASDAQ composite today. So we'll uh we'll we'll take that. And it looks like we actually got a pretty decent. close uh for the NASDAQ, uh up four
2:06
Unidentified speaker (speaker_1): tenths of a percent. And uh we'll see. It it looks like it closed in the middle and maybe even in the top half of its uh of its range today. So uh we will we will take that uh Ali. You can see multiple down days in a row for the for the Nasdaq, and it was a pretty good earnings report for uh NVIDIA. I don't think NVIDIA had a
2:27
Unidentified speaker (speaker_1): such such a great day by the close uh today, but we were uh we were hoping we were gonna be able to you know uh muscle out a a first day of a rally attempt for the Nasdaq and we were able to to get that uh today. So that's a a small a small win uh for you know the the stock market uh bulls out there. Um so we managed a small gain on the on
2:47
Unidentified speaker (speaker_1): the NASDAQ but um you know tough uh tough day for the broad market But again, you know, looking at uh at at growth stocks underneath uh the surface, and we were talking about this on IBD Live this morning. There was some, you know, a lot of a lot of good movement underneath uh the surface. Great action in uh in the retail sector today. That's been uh a sector that's been working uh pretty well. A
3:07
Unidentified speaker (speaker_1): lot of tech stocks under under pressure uh today despite that pretty good earnings uh from uh from NVIDIA uh last night.
3:14
Unidentified speaker (speaker_0): Yeah exactly and you mentioned retail so here's a look at the XRT ETF. It was up 2.3% on the day. So some nice our performance there. And since you brought up NVIDIA we will just go to that chart finishing down almost 3% on the day. So another stellar quarter not
3:34
Unidentified speaker (speaker_0): enough to lift the stock of course we know that there are other issues going on here, Ken, with the company. Uh, your thoughts and uh we can also take a look at some other sectors on your radar as well.
3:47
Unidentified speaker (speaker_1): Yeah, well, you should see NVIDIA did rally all the way up to that $160 level, but uh it was those gains were those gains were were short lived, and you can see uh this was for the actually for the quarter ended in October uh uh uh NVIDIA is uh three quarters of the way through
4:07
Unidentified speaker (speaker_1): its fiscal year uh twenty twenty-seven. So this was for the quarter ended in uh October, and you can see the the triple digit uh earnings and and revenue growth uh earnings doubled uh from a year ago, the revenue uh doubled again, uh, you know, and they they they they raised their uh fiscal twenty.
4:26
Unidentified speaker (speaker_1): 2028 revenue uh guidance uh seventy five percent top line growth uh as opposed to the uh seventy percent that uh factset was uh expecting. So you know the numbers were good and CFO uh or the interim CEO Colette uh Kress uh was really you know uh talking uh a uh a a a
4:46
Unidentified speaker (speaker_1): game of uh you know still strong demand but uh yeah, just uh a lot of uncertainty still about uh NVIDIA. The uh SEC investigation was uh launched uh yesterday. So we'll see what what comes and we'll see what uh what the future of uh Jensen uh Jensen Wong is. The new board uh chair at uh NVIDIA during the conference call,
5:06
Unidentified speaker (speaker_1): right at the right at the start of the conference call yesterday said that uh uh the board uh intends to hire a new CEO and that uh it does not plan on bringing Jensen Huang back, even though there's a a lot of people that would like to see him come back as uh CEO. Uh but the stock was not able to get out of its own way today. And uh I kind
5:26
Unidentified speaker (speaker_1): of kept a lid on uh the NASDAQ uh Nasdaq's uh gains uh today. But uh I think it was a small win that the Nasdaq was able to to close uh positive uh today because there still was quite a bit of selling uh underneath uh the surface in the technology sector in in general uh today. So, you know, we did get uh we
5:46
Unidentified speaker (speaker_1): did get the first day of a rally attempt for the Nasdaq, like I said, but tough uh reversal slightly lower for uh for NVIDIA today.
5:54
Unidentified speaker (speaker_0): Exactly. Uh and we already looked at the S P five hundred testing the two 200A hundred A line. What was up with uh the Dow today and an outside outsized decline here?
6:04
Unidentified speaker (speaker_1): Well, you just had more selling in those uh health insurers uh and uh that that we talked about uh yesterday. So remember that big decline we saw in United Health, uh UNH uh in the Dow. That was uh that extended losses uh today down another uh 10%. But that that fell that fell sharply
6:24
Unidentified speaker (speaker_1): uh yesterday. Saw So you know the news yesterday. and this hit names like United Health and CNC Centen and Humana, uh Cigna, all of these, uh, all of these stocks, ticker CI. You know, they the government is taking steps to kind of curtail uh fraud in the
6:44
Unidentified speaker (speaker_1): insurance uh uh uh sector. So um it's kind of a a convoluted uh story, but this was uh affecting the insurers and it it it first fueled some selling in the in the group uh yesterday but it really uh really fueled some selling uh today. Hospital operators, which had been leading uh the
7:03
Unidentified speaker (speaker_1): market, uh they were also weak today. I mean the healthcare sector in general, if you look at XLV, this was one of the worst performing uh SP sectors today. XL XLV V uh had been leading the market. Uh bad break of the 21-day moving average uh today. That was down more than uh two percent. But uh yeah,
7:23
Unidentified speaker (speaker_1): the Dow uh lag today, UNH was uh uh you know a weak performer. Uh energy prices were down uh sharply uh today, along with that uh 10-year treasury yield. But oil prices at last check, they were down close to four percent today. Oil uh uh the price of oil is down below eighty-three dollars a barrel. So I
7:43
Unidentified speaker (speaker_1): mean, oil is has really dropped uh you know precipitously. So you can see USO was down uh almost uh three percent uh today. And you know, we got another drop in that ten year treasury yield today. We had the Fed minutes uh you know came out at uh at two PM uh Eastern time today, and
8:01
Unidentified speaker (UNKNOWN): you know,
8:01
Unidentified speaker (speaker_1): we had uh the ten year treasury go back up uh again. That's down to about five point oh seven percent, testing the fifty day moving average. So a lot of moving parts uh to this market, uh Allie. Um yeah but the Fed is uh they're they're still you know talking about uh interest rate uh hike in uh in in December. You know, we had uh Fed
8:21
Unidentified speaker (speaker_1): Governor Waller, he was interviewed on on CNBC this morning by uh by Steve Lincoln Leisman. Uh Governor Waller, it was maybe a week or two ago, he initially spooked uh the market when he was talking about the possibility of a a 50 basis point rate hike in in December. He kind of
8:41
Unidentified speaker (speaker_1): floated that um and this maybe surprised the market a little bit and spooked the market. Well, this morning when he was in in uh on CNBC talking with Leisman, he said it uh really seems to be uh something that they are thinking more seriously about. This was one person's opinion, but Fed uh Governor Waller was talking with Leisman this morning
9:01
Unidentified speaker (speaker_1): and saying that uh he he really believes that a 50-point basis uh uh 50-point rate hike is uh needed at this point, especially in light of that consumer inflation that we saw uh last week. So that spooks spooked the market and it actually caused NVIDIA, which had a nice pre-market gain, and the Nasdaq 100 futures were
9:21
Unidentified speaker (speaker_1): up nicely. It caused the market to back off uh highs uh quite a bit. And his comments uh really caused the market to give back some of these early strong gains uh you know before the open. So yeah, we saw uh yields uh back up uh a little bit, and uh, you know, the Fed minutes uh came out. They really didn't move the market uh too much when the minutes uh came out, but
9:40
Unidentified speaker (speaker_1): uh yields uh you know coming in uh a little bit here so we'll see.
9:44
Unidentified speaker (speaker_0): Yeah. So the December decision on rates will be uh very closely followed.
9:51
Unidentified speaker (UNKNOWN): Yeah I
9:52
Unidentified speaker (speaker_1): th I think uh
9:52
Unidentified speaker (UNKNOWN): I
9:53
Unidentified speaker (speaker_1): I doubt I doubt it's gonna be uh you know we'll we'll see. I mean it's the chances are still if you look at the the Fed funds uh futures it's still pretty uh pretty slim chance it's gonna be uh uh they're gonna bring the bazooka out and and hike by uh
10:07
Unidentified speaker (UNKNOWN): a half
10:07
Unidentified speaker (speaker_1): a half a point. Uh it's you know possible, but not likely. We'll see. But you know, if if inflation continues to ramp, uh it's not out of the question, but not likely at this point. But a quarter point is uh is pretty much baked in at this point.
10:24
Unidentified speaker (speaker_0): Yeah, and then just from uh a market perspective.
10:27
Unidentified speaker (speaker_0): we were talking on IBD Live about the Q4 2018 market and and downturn there. And that coincided with a rate hike environment. So worth studying. We don't have to unpack that again right here. Uh, but let's take a look at some of the other areas
10:45
Unidentified speaker (UNKNOWN): that
10:46
Unidentified speaker (speaker_0): were notable today. Cybersecurity. We saw a lot of interesting movements. movers in this group today. Can this bug ETF up almost 8% on the day?
10:56
Unidentified speaker (speaker_1): Yeah, this was really uh almost uncanny because we'll take a look at uh Palo Alto Networks, which is reporting earnings after the close uh today. And Palo Alto has not had a really positive response the last three or four times its reported uh earnings. But in anticipation of this earnings report, you had just all sorts of security software stocks that were. materially
11:15
Unidentified speaker (speaker_1): outperforming at the open. They held strong gains throughout the day. So when you looked when you looked at um, you know, the market surge growth two fifty, you look inside the IBD fifty, we've got a lot of security software stocks that are top rated stocks in our in our database. And um, you know, they they just went uh you know, had
11:34
Unidentified speaker (UNKNOWN): scope
11:35
Unidentified speaker (speaker_1): yeah
11:35
Unidentified speaker (UNKNOWN): really really really
11:36
Unidentified speaker (speaker_1): nice uh gains. We looked at NetScope. not a widely known name in the in the security software group, but um you know uh a a fairly substantial a fairly substantial company, Cellpoint, uh another another uh you know, another fairly large uh company in in the group. So uh yeah you can see some of these
11:56
Unidentified speaker (speaker_1): uh security cyber security ETFs had uh had really nice uh really nice uh days uh today. So this was bug. Uh Hack uh I th I think we you just pulled up Hack uh Ha Hack uh was another ETF uh I don't know that that that uh went above its uh 50 day moving average. Uh tried to, but uh yeah some
12:16
Unidentified speaker (speaker_1): great outperformance from a lot of these uh security software stocks and um you know so that that's an area of tech that is still you know looking uh looking interesting. Uh some are still some former leaders are still below their fifty-day lines, but uh we saw a few names that uh actually are still looking pretty good here. But uh that's
12:36
Unidentified speaker (speaker_1): kind of the anomaly in the tech sector right now, the uh security software stocks. Most uh names, you know, AI stocks and the chip stocks have really fallen very, very far
12:47
Unidentified speaker (UNKNOWN): uh
12:47
Unidentified speaker (speaker_1): off off their highs. But uh great outperformance from a lot of the cyber. cybersecurity names today.
12:52
Unidentified speaker (speaker_0): Yes. And then uh you mentioned the weakness uh in the medical sector. So just wanted to quickly go to XLV down 2.2% on the day. And then XLY up 1.8%.
13:07
Unidentified speaker (speaker_0): What stood out to you today in consumer discretionary?
13:10
Unidentified speaker (speaker_1): Well this is you know the consumer discretionary some of the top holdings of uh of uh X XLY, uh Amazon obviously a big uh performer today. Amazon is a big holder or a big uh investor in anthropic along with uh Alphabet. Uh both Alphabet and Amazon uh own uh
13:30
Unidentified speaker (speaker_1): own a significant chunk of uh anthropic so I think between both of uh between Amazon and uh Google or Alphabet I think they own about thirty percent of uh Anthropics. So when this company comes uh public, uh both of these companies are you know own a own a sizable piece of uh anthropic. So uh Amazon
13:50
Unidentified speaker (speaker_1): had a nice uh a nice day today and uh you know amid a lot of uh kind of weakness in in the broad market and the Nasdaq very, you know, uh the the Nasdaq index looking very shaky from a technical perspective. It's interesting to see Amazon kind of setting up here and not that far from a uh you know from a from an entry
14:10
Unidentified speaker (speaker_1): point here. So you know nice day of outperformance for for Amazon and uh not far from a a breakout point here. So uh this uh IPO anthropic IPO that's supposed to price uh tonight heard rumblings on C CNBC N B C just a few minutes ago that um you know it's the the the the pricing was you know supposed to go
14:30
Unidentified speaker (speaker_1): off between seventy and and seventy eight, but there are rumblings that it's gonna go north of uh well north of uh eighty. So uh we will we will see where it eventually uh prices. But uh it could could be an interesting day considering that you know sentiment has been so weak in the AI
14:51
Unidentified speaker (speaker_1): space, you know. Um but we'll we'll see what
14:53
Unidentified speaker (UNKNOWN): we'll see what can be.
14:56
Unidentified speaker (UNKNOWN): Okay.
15:04
Unidentified speaker (speaker_1): Yeah. A lot of these IPOs that we have seen, uh anthropic could be a completely different animal, but uh some IPOs uh we've seen, Allie, they have not even started trading until nine. 9:30, 10 in the morning Pacific time. So sometimes it's three, four hours into the into the market open. Yeah. Anthropic could even
15:24
Unidentified speaker (speaker_1): take a little bit longer, so we'll have to to see. But likely not gonna not gonna not gonna start trading um for uh at least an hour or two um after the open. Probably probably longer. We'll have to we'll have to see.
15:37
Unidentified speaker (speaker_0): All right, interesting. And I just pulled up SpaceX because uh an interesting case study. Right. No two IPO is exactly the same, but uh some of them do tend to trade. How SpaceX traded. Uh, you know, a lot of hype.
15:53
Unidentified speaker (speaker_1): Yeah.
15:53
Unidentified speaker (speaker_0): So an initial burst, but hasn't really done a lot lately. So traders should just be careful out there, manage risk, wait for some sort of pattern to develop uh before before getting in. That's what we like to do.
16:09
Unidentified speaker (speaker_1): Yeah, normally I I thought I thought it was just uh interesting just watching how this uh anthropic IPO was was handled normally when uh when a uh a high profile you know IPO is is coming out. The underwriters are gonna take a look at what the what the market is looking like. They'll take a look at market conditions and if they feel the environment isn't
16:28
Unidentified speaker (speaker_1): right, if they feel like they're the IPO is coming out and uh there's just a lot of selling or or the they feel like the market isn't healthy, they'll they'll postpone the IPO. They'll shelve it and they'll they'll wait for uh a better time. But in a case like Anthropic, it's such a big and you know, it's just such such a big and widely anticipated IPO. I think they just wanted to
16:48
Unidentified speaker (speaker_1): to go go forward with it. But in a such situation like this, this this would have been uh uh uh uh uh an IPO where it would have been you know uh postponed just because of the just the situation of the market and especially just the the so the overall sentiment around uh AI stocks but uh I think this was just too big an IPO
17:08
Unidentified speaker (speaker_1): to to postpone. So they're gonna they're gonna give it a go and uh and uh and we'll see. But uh I think clearly their the the demand is uh is is strong or they wouldn't be talking about uh you know a higher going off at a higher price. So we'll see. It's likely gonna go off uh well above that seventy to seventy eight range just
17:28
Unidentified speaker (speaker_1): like you like you said here. So um we'll see where it eventually uh closes. Should be an interesting interesting day tomorrow.
17:36
Unidentified speaker (speaker_0): Okay. Yep, it sure will. Thanks for that, Ken. And let's now pivot to looking at Target, which attempted a breakout above a cup with handle buy point on earnings today. Shares finished the day up four percent, somewhat mid range. We could take a look at the exact closing range here in
17:56
Unidentified speaker (speaker_0): market surge. Uh exactly 50%. So right at the halfway uh point there. So uh we did get a blue dot given the current environment, Ken. And like you said, it was uh a pretty good quarter here. Earnings growth up forty-nine percent, single digit top line growth, but still
18:16
Unidentified speaker (speaker_0): some acceleration there up to seven percent. So a breakout of note today.
18:23
Unidentified speaker (speaker_1): Yeah, and uh they have a they have a new uh new CEO. in in place here that uh you know I think is uh is is going uh going pretty well. Target is uh you know spending uh a lot of money right now. Their their capital expenditures are are are are quite uh are quite high. They've been kind of
18:42
Unidentified speaker (speaker_1): refurbishing stores and kind of redoing their their product uh product lines. I I read in the press release they're they're carrying a whole lot of new products like priced under under five dollars for example uh that are are are are doing uh are doing well um
19:00
Unidentified speaker (UNKNOWN): you
19:00
Unidentified speaker (speaker_1): know so they're just they're they're doing a lot of new things just to bring uh to bring new customers uh to bring new customers uh through the the the doorway um their their traffic was up their same store sales were better than expected so overall the quarter was uh was was very, very strong and uh and the market rewarded uh
19:20
Unidentified speaker (speaker_1): rewarded the the share price. Uh so it was a a nice breakout from a classic uh cup with handle base. Uh you know, this is a tough environment for for technical breakouts. Volume expanded in the stock uh nicely uh today, but you can see sellers uh knocked the stock uh off uh off highs and um you know the this is um again just a diffic
19:40
Unidentified speaker (speaker_1): a difficult environment for technical breakouts. When you're in a good solid bull market and there's money coming in from the sidelines and uh you're in a good good strong uptrend, you tend to see breakouts uh close and finish near session highs. Uh here was a case where sellers kind of knocked to knock the stock off highs by the by the close, but um, you know,
20:00
Unidentified speaker (speaker_1): not not a not a terrible day. And um
20:03
Unidentified speaker (UNKNOWN): you know
20:03
Unidentified speaker (speaker_1): it's just uh closed off highs a little bit but overall a solid day, nice percentage gain and uh you know really, really strong uh quarter. That's the bottom line for for Target. They're gonna be spending a lot of money um in their their current uh fiscal fiscal year here as well, but the market uh doesn't seem to to mind because they're they're spending money to to make money
20:23
Unidentified speaker (speaker_1): and uh I think the market's uh okay with that as the they uh kind of you know turn around uh turn around the business and deal with this uh tremendous uh competition that they've been uh you know facing from the likes of Amazon and you know all these other all these other companies. But uh so far the turnaround's looking pretty good.
20:41
Unidentified speaker (speaker_0): Yeah, exactly. And then I think Target it's also gonna be good intel to see how does it handle this type of market environment. Can it extend gains after this breakout or is it just going to get dragged down with the overall market? I mean, that relative strength line is looking very
21:01
Unidentified speaker (speaker_0): strong
21:02
Unidentified speaker (speaker_0): for that 2026 time frame as a whole. So a standout, can that relative strength continue? We'll have to see. Let's go to RYTM R Y T M
21:14
Unidentified speaker (UNKNOWN): also.
21:14
Unidentified speaker (speaker_0): on your radar in the revenue biotech group. Ken. I'm gonna go out to the weekly chart here. Shares up about two percent on the day after a really nice upside reversal yesterday. The last couple of weeks, some really strong buying coming into this stock.
21:29
Unidentified speaker (speaker_1): Yeah, this is uh this is uh another this is a revenue uh it tracked in the revenue biotech uh group. So they're so they're generating they're generating revenue. and you can see that along the the bottom. They're not uh they're not profitable yet, but they are generating uh revenue from uh from an obesity drug, but not an
21:48
Unidentified speaker (speaker_1): obesity drug that uh that we know uh from the likes of uh Novo and uh and Eli Lilly. They are not competing with uh Novo and Eli Lilly. They have uh they they they treat uh a a very rare uh form uh uh j a genetic uh a genetic uh form of
22:09
Unidentified speaker (speaker_1): uh o obesity and uh it it's a it's a rare it's a a rare form of of uh uh like I said a genetic uh form of obesity that is uh that is treated with uh what W one of their approved FDA drugs and uh you can see that it's generating a fair amount of revenue for the company. MCVRI, I believe is
22:29
Unidentified speaker (speaker_1): the is the company, uh is the drug's uh name. Uh, but they're still spending a lot of money on uh on RD. The drug just got uh an additional uh indication approved, um, but uh still losing money. Uh but with these uh revenue biotechs, even though they're losing money, uh this is uh another uh biotech that is showing big,
22:49
Unidentified speaker (speaker_1): big increases in fund ownership. So uh you know when I'm researching a biotech stock and I see, you know, nice uh nice revenue and and an approved uh FDA uh drug, uh I like to look at the fund uh sponsorship and and see some really you know good funds in there. And uh Fidelity has got some
23:08
Unidentified speaker (speaker_1): uh fun uh some really top performing fund managers in here, um, particularly the uh let's see here.
23:21
Unidentified speaker (speaker_1): Let's
23:21
Unidentified speaker (speaker_0): check it out. I can s I can sort, I can find some uh some fidelity funds in here.
23:26
Unidentified speaker (speaker_1): Yeah, I thought I thought I thought Contra Fund was in this one, but uh I know Lord Lord Abbott is a is a good
23:31
Unidentified speaker (UNKNOWN): fund
23:31
Unidentified speaker (speaker_1): family in here.
23:34
Unidentified speaker (UNKNOWN): Yeah.
23:34
Unidentified speaker (speaker_0): There's fidelity
23:35
Unidentified speaker (UNKNOWN): We do have Fidelity. selects.
23:37
Unidentified speaker (speaker_0): Quite a few A rated
23:40
Unidentified speaker (UNKNOWN): Yeah,
23:40
Unidentified speaker (speaker_1): I see the Select Biotech uh in there. Yeah, I thought the Fidelity Series uh growth was in here. But anyway, a lot of funds in the fed in the uh in the IBD Mutual Fund Index uh in here. Uh see T Row Price uh New Horizons, Lord Abbott uh developing growth. That's an excellent uh fun family uh as well. So uh
24:00
Unidentified speaker (speaker_1): Rhythm Pharmaceuticals uh kind of came right out. up the uh right side of this latest uh uh base after reporting earnings, but uh holding on to these gains uh nicely and you know just really tried to come out of a very long uh consolidation here. So uh good revenue growth, uh good fun sponsorship. So we'll just kind of watch
24:20
Unidentified speaker (speaker_1): it uh hold gains here and see if it uh can eventually come out. But the biotechs are still seeing a lot of a lot of. money flow here. And this one uh you know $119 stock, so I would definitely call it an institutional quality uh biotech that is uh still under quite a bit of accumulation here. So
24:39
Unidentified speaker (speaker_1): good name to uh good name to watch and uh like the like the technicals uh here quite a
24:45
Unidentified speaker (UNKNOWN): bit
24:46
Unidentified speaker (speaker_0): all right and let's round things out with a look at AMG. Ken talk to us about why this is on your radar right now.
24:56
Unidentified speaker (speaker_1): Yeah, this is a you know totally different uh company. This is in the investment management group. So it's an asset manager, but not the type of asset manager you know. What this company does is they they go around and they they they uh buy stakes in a lot of uh small and medium size uh investment. uh boutiques. So
25:16
Unidentified speaker (speaker_1): they uh they're an asset manager but they they they buy you know stakes in these uh smaller boutiques and then they take a percentage of the revenue. So they own uh pieces of uh i investment boutiques and then so they have uh you know they offer a whole bunch of different investing strategies among
25:36
Unidentified speaker (speaker_1): all these uh among all these uh different uh you know boutiques and uh that's what that's why they're called i affiliated managers uh group. So it's not one big investing house but they own pieces of a lot of different uh uh you know investing houses and uh uh but they're they're they're an asset manager
25:56
Unidentified speaker (speaker_1): tracked in the investment management group and uh you know if you look at the the daily chart here this is a stock that has just moved back into a uh a buy zone let's look at the the daily chart here because the the um I want to just show you how like today it it moved showed good price action today it uh closed in the bottom half of its range but it
26:16
Unidentified speaker (speaker_1): moved back into a uh a a buy zone here from uh from a prior uh entry point you can see that blue shaded area so like I said it closed in the bottom half of its uh uh range here but uh again back in a buy zone look at that relative strength line poking back into uh into into new high uh ground
26:35
Unidentified speaker (speaker_1): here composite rating of uh of ninety seven here so um I think it's looking uh looking looking pretty good um when it uh when it rose uh maybe a a week or two ago and and moved into new high ground it did so in uh you know, good good good volume about two weeks ago. So um
26:55
Unidentified speaker (speaker_1): again, decent uh decent industry group here, filled with uh you know some some top performing stock. So nice, nice big uh company here, financial sector. Still seeing some decent leadership here. So affiliated managers group, AMG back uh in a buy zone here after some nice uh head. heavy volume
27:15
Unidentified speaker (speaker_1): gains uh back above its uh 50-day moving average looks pretty good too.
27:20
Unidentified speaker (speaker_0): All right. Thanks for putting it on our radar. We appreciate it, Ken, as always.
27:24
Unidentified speaker (speaker_1): Sure thing.
27:26
Unidentified speaker (UNKNOWN): All
27:26
Unidentified speaker (speaker_0): right, thanks everyone for tuning in. That's it from us for today, but it is Wednesday, so be sure to check out Investing with IBD, IEBD, our weekly podcast with host Justin Nielsen. That is going live around five. 5 p.m. Eastern on our YouTube channel. So check that out for a great discussion. And then the Thursday crew has you
27:46
Unidentified speaker (speaker_0): covered on IEBD Live tomorrow morning with your host, Rachel Fox. So we'll see you there, everyone. And then we'll also see you right back here tomorrow after the close.
28:11
Unidentified speaker (speaker_0): This show is for informational and educational purposes only, and nothing should be construed as a recommendation to buy, hold, or sell any securities. Any securities and investment strategies discuss may not be suitable for all investors. Make sure to consider consulting with your financial advisor before making investment decisions.
This page was produced automatically: the audio was transcribed with nvidia/parakeet-tdt-0.6b-v3+sortformer-v2.1 and interpreted by Qwen3.6-35B-A3B-UD-IQ3_S.gguf. Transcription and interpretation can contain errors; always confirm against the original episode. Nothing here is investment advice.

More from Stock Market Today With IBD

Stock Market Today With IBD

Dow Plunges 900 Points On Salesforce Carnage: Paycom, Ascendis, TGTX In Focus

Episode discussion: Market indices fall below 200-day moving averages as software stocks sell off; Paycom, Ascendis, and TGTX highlighted as potential opportunities

Speakers’ claims: Speakers analyze broad market weakness with the Nasdaq Composite, S&P 500, and Dow Jones Industrial Average trading below their 200-day moving averages. The sell-off was driven heavily by software stocks, particularly Salesforce, while chip stocks like those in the SMH ETF showed relative strength. Analysts identified Paycom (PAYC) as a resilient enterprise software stock holding above its 50-day moving average. Biotech stocks Ascendis Pharma (ASND) and TG Therapeutics (TGTX) were highlighted for strong fundamentals and technical setups. NVIDIA (NVDA) earnings were noted as positive despite recent declines, with focus shifting to leadership transition and China shipments.

Market Index TechnicalsSoftware SectorBiotech
29 min1 assets10 claims to verify
Stock Market Today With IBD

Defense Key As Stocks Lose Ground; Humana, Appian, Sezzle In Focus

Episode discussion: Market indexes break key technical levels prompting defensive cash positioning; Humana, Appian, Sezzle analyzed

Speakers’ claims: Alyssa Corum and Justin Nielsen report that major US equity indexes, including the Nasdaq Composite and S&P 500, declined significantly on November 16, 2026, breaking below the 21-day and 50-day moving averages. Justin Nielsen advises raising cash and avoiding trend-following strategies, noting that the previous follow-through day signal was suspect due to low volume and failed confirmation. While defensive sectors like staples and utilities showed relative strength, they failed to sustain gains, and Bitcoin's decline signaled broad risk-off sentiment. The hosts highlight Humana, Appian, and Sezzle as relative strength outliers but caution against chasing gains in a weak market environment.

Market TechnicalsPortfolio StrategySector Rotation
27 min1 assets10 claims to verify
All insights